The National Cancer Institute has awarded Dr. Sahin’s startup, LoxiGen, Inc., a three-year Fast-track Small Business Technology Transfer (STTR) grant to develop therapy for drug-resistant TNBC in collaboration with scientist at MUSC and USC

Published by sahinozgur on

Related Posts

Announcement

Ozge has been awarded the highly prestigious Scholar-in-Training Award by the AACR

Ozge Saatci received the Scholar-in-Training award to attend the American Association for Cancer Research conference and present her research. Here is the press release: https://hollingscancercenter.musc.edu/news/archive/2023/04/24/hollings-team-ids-protein-that-helps-cancer-cells-in-cell-division-process

Announcement

Our new paper is published in Cell Death & Differentiation

Our latest article has been published in Cell Death & Differentiation. The study focuses on the molecular mechanism of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) in highly aggressive breast tumors with Centrosome amplification (CA). Read more…

Announcement

A new postdoctoral fellowship position is available!

Postdoctoral Fellow position to contribute to cancer biology research at the intersection of drug resistance, metastasis, and drug discovery in breast cancer. The Sahin Lab in the Department of Biochemistry and Molecular Biology & Hollings Read more…